SCL Science Inc. (KOSDAQ:246960)

Kronos Bio Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,974	937.09	5,045	1,821	1,031	575.63
Short-Term Investments	8,393	176.5	4,068	3,086	9,398	4,081
Cash & Short-Term Investments	11,368	1,114	9,113	4,908	10,428	4,657
Cash Growth	91.86%	-87.78%	85.69%	-52.94%	123.93%	-56.85%
Accounts Receivable	5,764	2,115	643.1	96.46	81.23	128.17
Other Receivables	2,943	337.91	444.26	75.49	145.86	81.53
Receivables	8,707	2,453	1,087	171.95	227.09	509.69
Inventory	1,216	597.1	264.87	305.55	148.66	156.19
Prepaid Expenses	140.54	32	22.5	21.36	22.3	48.23
Other Current Assets	1,973	1,258	58.47	62.89	31.61	148.34
Total Current Assets	23,404	5,453	10,546	5,469	10,858	5,519
Property, Plant & Equipment	15,691	9,788	15,774	13,882	10,460	4,680
Long-Term Investments	4,305	3,945	2,321	10,368	9,786	6,544
Other Intangible Assets	2,352	2,442	153.44	713.9	213.93	152.18
Long-Term Accounts Receivable	-	-	-	-	0	-
Long-Term Deferred Charges	2,435	2,250	1,013	-	-	-
Other Long-Term Assets	267.46	179.39	350.16	381.8	245.25	174.71
Total Assets	57,579	24,057	30,158	30,814	31,883	17,351
Accounts Payable	1,287	1.54	0.68	18.45	2.63	4.66
Accrued Expenses	650.58	120.99	92.94	87.4	98.03	78.74
Short-Term Debt	1,794	400.89	347.83	-	-	-
Current Portion of Long-Term Debt	3,065	380.83	1,123	1,773	242.53	300
Current Portion of Leases	951.02	211.98	158.03	107.27	121.5	116.33
Current Income Taxes Payable	-	-	0.32	-	-	-
Current Unearned Revenue	-	-	-	-	45.83	45.83
Other Current Liabilities	2,006	2,266	1,632	479.01	146.89	290.29
Total Current Liabilities	9,753	3,382	3,356	2,465	657.42	835.85
Long-Term Debt	15,158	3,050	6,272	10,342	17,046	2,420
Long-Term Leases	2,242	215.26	193.87	22.43	127.78	208.65
Long-Term Deferred Tax Liabilities	413.46	291.09	364.81	783.76	-	-
Other Long-Term Liabilities	1,719	37.31	108.73	3,462	2,958	110.63
Total Liabilities	31,083	8,465	11,255	17,645	21,681	4,327
Common Stock	4,240	3,642	3,618	2,800	2,522	2,522
Additional Paid-In Capital	59,793	47,776	47,370	38,488	32,647	30,452
Retained Earnings	-41,231	-39,616	-35,702	-32,160	-26,008	-21,004
Comprehensive Income & Other	3,636	3,715	3,616	3,918	917.83	972.94
Total Common Equity	26,421	15,517	18,903	13,045	10,079	12,943
Minority Interest	-	-	-	123.91	122.74	81.28
Shareholders' Equity	26,496	15,593	18,903	13,169	10,202	13,024
Total Liabilities & Equity	57,579	24,057	30,158	30,814	31,883	17,351
Total Debt	23,210	4,259	8,095	12,245	17,537	3,045
Net Cash (Debt)	-11,843	-3,145	1,018	-7,337	-7,109	1,612
Net Cash Growth	-	-	-	-	-	-83.50%
Net Cash Per Share	-406.87	-108.23	40.51	-347.24	-352.34	79.89
Filing Date Shares Outstanding	33.92	29.13	28.95	22.4	20.18	20.18
Total Common Shares Outstanding	33.92	29.13	28.95	22.8	20.18	20.18
Working Capital	13,651	2,071	7,191	3,004	10,200	4,684
Book Value Per Share	778.98	532.63	653.01	572.11	499.53	641.46
Tangible Book Value	15,194	13,076	18,749	12,331	9,865	12,790
Tangible Book Value Per Share	447.97	448.81	647.71	540.81	488.92	633.92
Land	4,289	3,193	7,264	6,607	4,763	1,208
Buildings	6,656	4,656	6,600	5,657	3,874	2,231
Machinery	800.96	577	460.24	602.14	451.66	334.17
Construction In Progress	-	-	-	-	-	460

Source: S&P Global Market Intelligence. Standard template. Financial Sources.